Ventyx Biosciences
VTYX
VTYX
104 hedge funds and large institutions have $1.41B invested in Ventyx Biosciences in 2022 Q3 according to their latest regulatory filings, with 44 funds opening new positions, 29 increasing their positions, 20 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
45% more repeat investments, than reductions
Existing positions increased: 29 | Existing positions reduced: 20
11.64% more ownership
Funds ownership: 68.1% → 79.74% (+12%)
12% less call options, than puts
Call options by funds: $1.97M | Put options by funds: $2.25M
Holders
104
Holding in Top 10
6
Calls
$1.97M
Puts
$2.25M
Top Buyers
| 1 | +$60.7M | |
| 2 | +$48.9M | |
| 3 | +$47.7M | |
| 4 |
PAMS
Pictet Asset Management (Switzerland)
Geneva 73,
Switzerland
|
+$37.4M |
| 5 |
BC
Boxer Capital
San Diego,
California
|
+$29.7M |
Top Sellers
| 1 | -$31.9M | |
| 2 | -$31.4M | |
| 3 | -$30M | |
| 4 |
VC
Vivo Capital
Palo Alto,
California
|
-$19.8M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$14.7M |